−2.32 B KRW
496.65 M KRW
About ANGIOLAB
Sector
Industry
CEO
Min-Yeong Kim
Website
Headquarters
Daejeon
Founded
1999
ISIN
KR7251280004
FIGI
BBG00F0XD231
AngioLab, Inc. engages in the development, manufacture, and distribution of pharmaceutical products. Its products include treatment for wet macular degeneration, nonalcoholic fatty liver disease treatment, periodontal disease treatment, treatment of otitis media with effusion, injection dermatitis remedy, antibody therapy, and foods that reduce visceral fat. The company was founded by Min-Yeong Kim on June 3, 1999 and is headquartered in Daejeon, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 251280 is 7,750 KRW — it hasn't changed in the past 24 hours. Watch ANGIOLAB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange ANGIOLAB stocks are traded under the ticker 251280.
251280 stock has risen by 0.52% compared to the previous week, the month change is a 7.49% rise, over the last year ANGIOLAB has showed a 29.60% increase.
251280 reached its all-time high on Oct 29, 2018 with the price of 25,800 KRW, and its all-time low was 3,000 KRW and was reached on Mar 18, 2024. View more price dynamics on 251280 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
251280 stock is 0.00% volatile and has beta coefficient of −0.77. Track ANGIOLAB stock price on the chart and check out the list of the most volatile stocks — is ANGIOLAB there?
Today ANGIOLAB has the market capitalization of 23.02 B, it has decreased by −1.27% over the last week.
Yes, you can track ANGIOLAB financials in yearly and quarterly reports right on TradingView.
No, 251280 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jan 22, 2025, the company has 16.00 employees. See our rating of the largest employees — is ANGIOLAB on this list?
Like other stocks, 251280 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ANGIOLAB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ANGIOLAB technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ANGIOLAB stock shows the buy signal. See more of ANGIOLAB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.